US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Johnson & Johnson

154.58

-0.3500-0.23%

Post-market: 153.90-0.6801-0.44%19:57 EDT

Volume:8.64M

Turnover:1.33B

Market Cap:371.93B

PE:17.20

High:154.90

Open:154.32

Low:152.45

Close:154.93

Loading ...

Overview Company News Filings

STAAR Surgical Announces Realignment of Leadership Structure

Johnson & Johnson (JNJ) Rises But Trails Market: What Investors Should Know

BRIEF-Nanobiotix amends global licensing agreement for JNJ-1900 (NBTXR3)

Nanobiotix Sa: Amended Agreement Enabled Nanobiotix to Strengthen Financial Position, Extending Cash Visibility to Mid-2026

THOMSON REUTERS

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Johnson & Johnson (JNJ) Could Be a Great Choice

Big Pharma Walked Away From Mental Health. Why Some Are Coming Back. -- Heard on the Street -- WSJ

Johnson & Johnson (JNJ): “Breakout or Breakdown?” – Jim Cramer Says JNJ Must Fall for Market to Bottom

FACTBOX-Trump's tariffs and threatened trade actions

Johnson & Johnson (NYSE:JNJ) Faces Shareholder Activism Over Human Rights and Executive Pay Proposals

Simply Wall St.

Johnson & Johnson’s Strategic Shift to Comprehensive Procedural Solutions Drives Buy Rating

Pharma Stock Roundup: RHHBY Obesity Drug Rights Buyout, NVO Pipeline Update

Press Release: AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update

Johnson & Johnson (NYSE:JNJ) Reports Positive Phase 2b Trial Results For Ulcerative Colitis Treatment

Simply Wall St.

PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study

Protagonist Therapeutics Soars as Icotrokinra Drives Breakthrough Success

TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors

ACCESS Newswire

Breakfast News: The Rout Continues

Genmab sinks as J&J opts not to develop Darzalex successor; stock upgraded

BUZZ-Genmab falls after J&J Hexabody opt-out

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/JNJ/news?page=19"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JNJ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JNJ\",,,,,undefined,":{"symbol":"JNJ","market":"US","secType":"STK","nameCN":"Johnson & Johnson","latestPrice":154.58,"timestamp":1745611200000,"preClose":154.93,"halted":0,"volume":8643927,"hourTrading":{"tag":"盘后","latestPrice":153.8999,"preClose":154.58,"latestTime":"19:57 EDT","volume":241532,"amount":37335647.5779,"timestamp":1745625466923},"delay":0,"floatShares":2402378994,"shares":2406073279,"eps":8.984973,"marketStatus":"Market Closed","change":-0.35,"latestTime":"04-25 16:00:00 EDT","open":154.32,"high":154.9,"low":152.45,"amount":1330911231.6210902,"amplitude":0.015814,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.984973,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":-797371200000,"exchange":"NYSE","adjPreClose":154.93,"dividendRate":0.032087,"preHourTrading":{"tag":"盘前","latestPrice":154.26,"preClose":154.93,"latestTime":"09:29 EDT","volume":3621,"amount":560780.2869,"timestamp":1745587772890},"postHourTrading":{"tag":"盘后","latestPrice":153.8999,"preClose":154.58,"latestTime":"19:57 EDT","volume":241532,"amount":37335647.5779,"timestamp":1745625466923},"volumeRatio":1.033507316421939,"optionData":{"bulkOrders":[{"symbol":"JNJ","call":true,"expireDate":1745553600000,"strike":"155.0","timestamp":1745588586409,"price":0.2,"volume":1994,"amount":39880,"type":"+"}]},"impliedVol":0.2478,"impliedVolPercentile":0.936},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JNJ\",,,,,undefined,":{"symbol":"JNJ","floatShares":2402378994,"roa":"7.74%","roe":"29.45%","lyrEps":5.84306,"volumeRatio":1.033507316421939,"shares":2406073279,"dividePrice":4.96,"high":154.9,"amplitude":0.015814,"preClose":154.93,"low":152.45,"week52Low":140.68,"pbRate":"4.76","psRate":"4.16","week52High":169.99,"institutionHeld":0.6213,"latestPrice":154.58,"eps":8.984973,"divideRate":0.032087,"volume":8643927,"delay":0,"ttmEps":8.984973,"open":154.32,"prevYearClose":144.62,"prevWeekClose":157.47,"prevMonthClose":165.84,"prevQuarterClose":165.84,"fiveDayClose":157.47,"twentyDayClose":163.13,"sixtyDayClose":151.15},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JNJ\",pageSize:20,pageCount:19,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520381746","title":"STAAR Surgical Announces Realignment of Leadership Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2520381746","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520381746?lang=en_us&edition=fundamental","pubTime":"2025-03-18 06:30","pubTimestamp":1742250600,"startTime":"0","endTime":"0","summary":"Warren Foust Named President and Chief Operating Officer. Deborah Andrews, STAAR’s Chief Financial Officer from 2017- 2020, to serve as Interim Chief Financial Officer. Patrick F. Williams Steps Down as Chief Financial Officer. Deborah Andrews, who retired from STAAR in 2020 and previously served as STAAR’s Chief Financial Officer from 2007-2013 and 2017-2020, has been appointed to the role of Interim CFO, effective immediately. STAAR’s Board of Directors will be initiating a search for a permanent CFO. Patrick F. Williams, who joined STAAR as CFO in 2020, is stepping down effective immediately, and he has agreed to a three-month consulting agreement to assist with the transition of responsibilities. Mr. Williams’ departure is part of the Company’s overall leadership realignment and is not related to any disagreement regarding financial reporting or internal controls.Mr. Farrell continued, \"I am also honored to have a leader of Magda’s caliber in charge of our R&D effort","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/staar-surgical-announces-realignment-leadership-223000673.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1061106388.HKD","LU1066051498.USD","LU1057294990.SGD","LU0234572021.USD","SG9999001440.SGD","IE00BDGV0183.EUR","JNJ","LU2129689605.HKD","LU0203345920.USD","LU0912757837.SGD","BK4581","LU2430703251.USD","IE00B3PB1722.GBP","LU1894683348.USD","STAA","LU2468319806.SGD","IE00BGHQF631.EUR","LU2430703178.SGD","IE000M9KFDE8.USD","IE00BFTCPJ56.SGD","LU1674673428.USD","IE00B19Z3B42.SGD","LU0466842654.USD","IE00B7SZLL34.SGD","BK4504","LU1718418525.SGD","LU2602419157.SGD","LU1244550577.SGD","BK4585","SG9999002232.USD","IE00BSNM7G36.USD","LU2133065610.SGD","BK4592","LU2347655156.SGD","LU1267930813.SGD","IE00BJJMRZ35.SGD","LU0889566641.SGD","LU1162221912.USD","BK4534","LU1894683264.USD","LU1196500208.SGD","LU0345770308.USD","IE00BJT1NW94.SGD","LU0203347892.USD","IE00B4R5TH58.HKD","LU2089984988.USD","LU0345769631.USD","LU1280957306.USD","IE00B1BXHZ80.USD","IE0002141913.USD"],"gpt_icon":0},{"id":"2520389466","title":"Johnson & Johnson (JNJ) Rises But Trails Market: What Investors Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2520389466","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520389466?lang=en_us&edition=fundamental","pubTime":"2025-03-18 05:45","pubTimestamp":1742247915,"startTime":"0","endTime":"0","summary":"In the latest trading session, Johnson & Johnson  closed at $162.84, marking a +0.02% move from the previous day. This change lagged the S&P 500's 0.64% gain on the day. Elsewhere, the Dow saw an upswing of 0.85%, while the tech-heavy Nasdaq appreciated by 0.31%.Shares of the world's biggest maker of health care products witnessed a gain of 4.27% over the previous month, beating the performance of the Medical sector with its loss of 0.88% and the S&P 500's loss of 7.69%.Market participants will be closely following the financial results of Johnson & Johnson in its upcoming release. The company plans to announce its earnings on April 15, 2025. The company's upcoming EPS is projected at $2.59, signifying a 4.43% drop compared to the same quarter of the previous year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $21.66 billion, up 1.29% from the year-ago period.The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnson-jnj-rises-trails-214515220.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0234570918.USD","IE00BDGV0183.EUR","BK4504","LU0345769631.USD","BK4211","IE0002270589.USD","LU1066051225.USD","LU1032466523.USD","LU0345769128.USD","LU0203345920.USD","LU1061106388.HKD","LU0114720955.EUR","LU2112291526.USD","LU1066051811.HKD","LU1280957306.USD","LU1074936037.SGD","LU0882574055.USD","LU0640476718.USD","IE000M9KFDE8.USD","LU1244550577.SGD","LU0345770993.USD","LU2468319806.SGD","JNJ","LU0795875086.SGD","LU1162221912.USD","LU1778281490.HKD","LU1585245621.USD","IE00B19Z3581.USD","LU0889566641.SGD","ISBC","IE00B1BXHZ80.USD","LU0320765646.SGD","LU0122379950.USD","BK4007","LU0912757837.SGD","LU1894683348.USD","LU2602419157.SGD","BK4592","SG9999001440.SGD","LU1732799900.SGD","IE00B19Z3B42.SGD","LU1506573853.SGD","LU2089984988.USD","LU0466842654.USD","LU1023059063.AUD","LU1261432733.SGD","LU2347655156.SGD","LU0795875169.SGD","LU0234572021.USD","LU0203347892.USD"],"gpt_icon":0},{"id":"2520668911","title":"BRIEF-Nanobiotix amends global licensing agreement for JNJ-1900 (NBTXR3)","url":"https://stock-news.laohu8.com/highlight/detail?id=2520668911","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520668911?lang=en_us&edition=fundamental","pubTime":"2025-03-18 05:17","pubTimestamp":1742246249,"startTime":"0","endTime":"0","summary":"BRIEF-Nanobiotix amends global licensing agreement for JNJ-1900 (NBTXR3)March 17 (Reuters) - Nanobiotix SA NANOB.PA:NANOBIOTIX STRENGTHENS FINANCIAL POSITION THROUGH AMENDMENT OF GLOBAL LICENSING AGRE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nTUA60NZWD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU2592432038.USD","LU0889566641.SGD","LU2505996681.GBP","LU0345769631.USD","LU1032955483.USD","LU1244550221.USD","LU1244550577.SGD","LU0234572021.USD","LU1929549753.HKD","BK4568","LU0203345920.USD","BK4532","BK4588","LU1023059063.AUD","LU1914381329.SGD","IE00BVYPNW00.USD","LU1061106388.HKD","BK4585","BK4559","LU2602419157.SGD","LU2430703178.SGD","LU0912757837.SGD","LU1585245621.USD","LU2468319806.SGD","JNJ","IE00B3PB1722.GBP","LU1674673428.USD","LU1221951129.SGD","LU0122379950.USD","IE0009355771.USD","LU0098860793.USD","LU1066051225.USD","LU1162221912.USD","LU1732799900.SGD","LU1057294990.SGD","IE00BGHQF631.EUR","LU0345770993.USD","LU0795875169.SGD","LU2112291526.USD","LU1732800096.USD","BK4534","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU0345770308.USD","LU1196500208.SGD","LU1066051498.USD","LU1032466523.USD","LU0345769128.USD","LU1778281490.HKD"],"gpt_icon":0},{"id":"2520950683","title":"Nanobiotix Sa: Amended Agreement Enabled Nanobiotix to Strengthen Financial Position, Extending Cash Visibility to Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2520950683","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520950683?lang=en_us&edition=fundamental","pubTime":"2025-03-18 04:15","pubTimestamp":1742242501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nTUA60NZWD:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1929549753.HKD","LU0795875086.SGD","BK4534","LU1914381329.SGD","BK4532","LU2133065610.SGD","LU0234572021.USD","LU2089984988.USD","SG9999001440.SGD","LU0912757837.SGD","LU0114720955.EUR","LU1244550577.SGD","LU0345769128.USD","LU1244550221.USD","LU1935042991.SGD","LU2592432038.USD","IE0002141913.USD","IE00B19Z3B42.SGD","LU2505996509.AUD","LU0203345920.USD","LU1778281490.HKD","IE00BFTCPJ56.SGD","IE0002270589.USD","LU0889566641.SGD","LU1894683264.USD","BK4568","IE00BJT1NW94.SGD","LU1066051811.HKD","LU1162221912.USD","LU1506573853.SGD","LU2112291526.USD","LU2430703178.SGD","IE0034235303.USD","BK4559","LU0122379950.USD","JNJ","LU1066053197.SGD","LU2129689605.HKD","IE00BVYPNW00.USD","IE00BSNM7G36.USD","LU0795875169.SGD","LU1674673691.USD","LU2505996681.GBP","LU2347655156.SGD","IE00B4R5TH58.HKD","LU0792757196.USD","LU1732799900.SGD","LU1261432733.SGD","LU0882574055.USD","BK4588"],"gpt_icon":0},{"id":"2520757045","title":"How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2520757045","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520757045?lang=en_us&edition=fundamental","pubTime":"2025-03-17 21:00","pubTimestamp":1742216404,"startTime":"0","endTime":"0","summary":"Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure helps cut through all the noise.Life and the stock market are both about expectations, and rising above what is expected is often rewarded, while falling short can come with negative consequences. Investors might want to try to capture stronger returns by finding positive earnings surprises.The final step today is to look at a stock that meets our ESP qualifications. Johnson & Johnson  earns a Zacks Rank #3 29 days from its next quarterly earnings release on April 15, 2025, and its Most Accurate Estimate comes in at $2.61 a share.JNJ is one of just a large database of Medical stocks with positive ESPs. Another solid-looking stock is Catalyst Pharmaceutical .Johnson & Johnson  : Free Stock Analysis Report","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/boost-portfolio-top-medical-stocks-130004572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CPRX","JNJ"],"gpt_icon":0},{"id":"2519380056","title":"Johnson & Johnson (JNJ) Could Be a Great Choice","url":"https://stock-news.laohu8.com/highlight/detail?id=2519380056","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519380056?lang=en_us&edition=fundamental","pubTime":"2025-03-14 23:45","pubTimestamp":1741967105,"startTime":"0","endTime":"0","summary":"All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.Cash flow can come from bond interest, interest from other types of investments, and of course, dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its dividend yield, a metric that measures a dividend as a percent of the current stock price. Many academic studies show that dividends account for significant portions of long-term returns, with dividend contributions exceeding one-third of total returns in many cases.Johnson & Johnson  is headquartered in New Brunswick, and is in the Medical sector. The stock has seen a price change of 12.7% since the start of the year. Currently paying a dividend of $1.24 per share, the company has a dividend yield of 3.04%. In compa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnson-jnj-could-great-154505500.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0002270589.USD","LU1032466523.USD","LU1929549753.HKD","IE0002141913.USD","LU1066051498.USD","BK4581","IE00BVYPNW00.USD","LU2129689431.USD","LU1057294990.SGD","BK4532","LU1280957306.USD","LU1066051225.USD","LU0345770993.USD","LU1935042991.SGD","IE00BFTCPJ56.SGD","IE00BGHQF631.EUR","LU1267930813.SGD","BK4585","BK4588","LU1244550221.USD","IE00BJT1NW94.SGD","LU0234570918.USD","LU1718418525.SGD","JNJ","BK4568","LU1032955483.USD","LU2592432038.USD","LU2430703178.SGD","LU2602419157.SGD","LU1674673691.USD","IE0009355771.USD","IE0034235303.USD","SG9999001440.SGD","LU2430703251.USD","BK4592","LU0289739699.SGD","IE00B7SZLL34.SGD","LU0114720955.EUR","LU1506573853.SGD","BK4504","LU0882574055.USD","LU2129689605.HKD","CHH","LU1061106388.HKD","LU0795875086.SGD","LU1732800096.USD","IE00BSNM7G36.USD","LU1244550577.SGD","LU0345769631.USD","LU0466842654.USD"],"gpt_icon":0},{"id":"2519878426","title":"Big Pharma Walked Away From Mental Health. Why Some Are Coming Back. -- Heard on the Street -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2519878426","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519878426?lang=en_us&edition=fundamental","pubTime":"2025-03-14 17:30","pubTimestamp":1741944600,"startTime":"0","endTime":"0","summary":"Modern society's relationship with mental health has evolved in recent decades. Once taboo, conditions such as depression and bipolar disorder are now openly discussed by high-profile figures like Simone Biles and Mariah Carey. Governments and employers worldwide have expanded access to care.Yet pharmaceutical innovation hasn't kept pace. Since the blockbuster success of drugs such as Prozac and Zoloft in the 1990s and early 2000s, many of the industry's largest companies have scaled back their investments in the field.This isn't for lack of patient demand. More than one in five Americans lives with a mental illness, and existing treatments often have significant side effects and limited effectiveness.Now, signs of a cautious revival are emerging. In late 2023, Bristol Myers Squibb acquired Karuna Therapeutics for $14 billion, betting on a promising new schizophrenia treatment. And in January, Johnson & Johnson agreed to acquire Intra-Cellular Therapies  for $15 billion, adding a pill ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","LU0306807586.USD","LU2112291526.USD","LU1003077747.HKD","NBIX","IE0004445239.USD","LU1023059063.AUD","IE00B3PB1722.GBP","LU0823416689.USD","LU2265009873.SGD","SGXZ57979304.SGD","BK4504","LU0203202063.USD","LU2357305700.SGD","BK4559","IE00B2B36J28.USD","BK4139","LU0211328371.USD","LU0345769128.USD","LU0912757837.SGD","BK4568","LU0234570918.USD","LU1718418525.SGD","SG9999014880.SGD","BK4585","LU0861579265.USD","LU1674673691.USD","LU1868836757.USD","IE00BDGV0183.EUR","ITCI","LU2505996509.AUD","SG9999014898.SGD","LU1196500208.SGD","LU0868494617.USD","BMY","SG9999015952.SGD","LU1989772840.SGD","SG9999017495.SGD","LU1069344957.HKD","LU0094547139.USD","LU0079474960.USD","LU2063271972.USD","SGXZ99366536.SGD","LU0661504455.SGD","LU1291159041.SGD","LU0965509283.SGD","JNJ","LU1280957306.USD","SG9999018857.SGD"],"gpt_icon":1},{"id":"2519891987","title":"Johnson & Johnson (JNJ): “Breakout or Breakdown?” – Jim Cramer Says JNJ Must Fall for Market to Bottom","url":"https://stock-news.laohu8.com/highlight/detail?id=2519891987","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519891987?lang=en_us&edition=fundamental","pubTime":"2025-03-14 08:19","pubTimestamp":1741911573,"startTime":"0","endTime":"0","summary":"We recently published a list of Jim Cramer Discusses These 11 Stocks & Says Trump’s ‘Soft’ On Tariffs Amidst $4 Trillion Wipeout. In this article, we are going to take a look at where Johnson & Johnson  stands against other stocks that Jim Cramer discusses.In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer continued to share his thoughts about the massive stock market crash on Monday. The tumble saw the flagship S&P index lose $4 trillion from its February peak to end up lower since President Trump’s election win. Naturally, Cramer was full of thoughts about the President and how he might help markets. He started by outlining that the narrative surrounding tariffs could hurt President Trump, despite the fact that the US might very well need tariffs to balance the scales of global trade in its favor.“If the President were to be a little more like Theodore Roosevelt, little less like McKinley, by the way, who was really anti-working man, praising McKinley. . . I like these","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnson-jnj-breakout-breakdown-001933360.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4534","BK4585","LU1244550494.USD","SG9999001440.SGD","IE00BSNM7G36.USD","IE00B1BXHZ80.USD","LU0114720955.EUR","LU0058720904.USD","IE00B19Z3581.USD","IE00BVYPNV92.GBP","BK4533","LU1066053197.SGD","IE00B7SZLL34.SGD","LU1066051225.USD","LU0795875169.SGD","JNJ","LU1196500208.SGD","LU1244550577.SGD","LU1267930813.SGD","BK4504","LU1732800096.USD","BK4007","LU2347655156.SGD","LU1430594728.SGD","LU0234570918.USD","LU0345769631.USD","LU2129689431.USD","LU2430703251.USD","LU0320765646.SGD","LU2592432038.USD","IE00BJT1NW94.SGD","IE0034235303.USD","LU1074936037.SGD","BK4532","LU2468319806.SGD","IE000M9KFDE8.USD","LU1506573853.SGD","IE00B4R5TH58.HKD","LU0640476718.USD","LU2602419157.SGD","LU1718418525.SGD","LU0889566641.SGD","IE00BDGV0183.EUR","IE00BFTCPJ56.SGD","BK4550","IE0009355771.USD","LU1244550221.USD","BK4568","LU0345769128.USD","BK4588"],"gpt_icon":0},{"id":"2519606998","title":"FACTBOX-Trump's tariffs and threatened trade actions","url":"https://stock-news.laohu8.com/highlight/detail?id=2519606998","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519606998?lang=en_us&edition=fundamental","pubTime":"2025-03-14 05:50","pubTimestamp":1741902621,"startTime":"0","endTime":"0","summary":"FACTBOX-Trump's tariffs and threatened trade actionsUpdates throughout","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"24cb068d33b7ba168e3db63aa6fd8cf5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nL4N3PW1HH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","PUBC","NVDS.UK","LU1803068979.SGD","LU0661504455.SGD","IE00BMPRXN33.USD","LU1815333072.USD","IE0034235295.USD","LU1267930573.SGD","LU0528227936.USD","LU2430703251.USD","SNVD.UK","MACW.SI","LU2063271972.USD","NVD2.UK","NVDS","IE00BQXX3C00.GBP","NVD3.UK","LU2430703178.SGD","LU0321505439.SGD","BK4548","NVDY","SG9999011175.SGD","LU0882574139.USD","LU0289960550.SGD","JNJ","NVDU","GM","BK4505","3NVD.UK","LU0289739343.SGD","LU2286300806.USD","NVIW.SI","SG9999001424.SGD","NVDD","LU0965509283.SGD","2NVD.UK","IE0004086264.USD","BK4533","LU0889566641.SGD","LU1571399168.USD","LU1861220033.SGD","LU2023250843.SGD","LU1032955483.USD"],"gpt_icon":1},{"id":"2519286181","title":"Johnson & Johnson (NYSE:JNJ) Faces Shareholder Activism Over Human Rights and Executive Pay Proposals","url":"https://stock-news.laohu8.com/highlight/detail?id=2519286181","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519286181?lang=en_us&edition=fundamental","pubTime":"2025-03-14 01:28","pubTimestamp":1741886924,"startTime":"0","endTime":"0","summary":"Johnson & Johnson is currently addressing shareholder proposals regarding executive compensation and human rights assessments, with recommendations to vote against them at its annual meeting on April 24, 2025. This may have contributed to the company's recent 11% price increase over the last quarter. During the same period, Johnson & Johnson declared a cash dividend for the first quarter of 2025 and announced positive financial results, with Q4 sales rising to $22.52 billion despite a drop in net income from the previous year. Additionally, pivotal product developments like positive findings from the ANTHEM-UC Phase 2b study for ulcerative colitis and an FDA approval for SPRAVATO as a monotherapy for major depressive disorder contributed to boosting investor sentiment. These developments occurred amidst a broader market environment that has experienced fluctuations, with the S&P 500 dropping 9% from its record high, largely influenced by economic uncertainties, including potential tari","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnson-nyse-jnj-faces-172844243.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BVYPNV92.GBP","LU1732800096.USD","IE00B19Z3581.USD","LU2129689605.HKD","BK4568","IE00B42XCP33.USD","LU1221951129.SGD","LU1244550494.USD","LU0114720955.EUR","LU0122379950.USD","IE00BVYPNW00.USD","LU2430703178.SGD","LU2129689514.USD","LU2430703251.USD","LU0203347892.USD","JNJ","LU0234572021.USD","LU1261432733.SGD","BK4550","LU0289739699.SGD","LU0345769631.USD","LU1674673691.USD","LU2505996509.AUD","NYSE","LU1061106388.HKD","LU1430594728.SGD","IE00BJT1NW94.SGD","LU1221951046.USD","LU1066053197.SGD","LU2602419157.SGD","LU1506573853.SGD","LU0345770993.USD","IE00B7SZLL34.SGD","IE0002141913.USD","IE00BDGV0183.EUR","SG9999002224.SGD","LU1032466523.USD","LU0345770308.USD","LU1162221912.USD","LU0320765646.SGD","BK4533","LU0640476718.USD","BK4532","LU0882574055.USD","LU1280957306.USD","LU1914381329.SGD","IE00B4R5TH58.HKD","LU0098860793.USD","LU1585245621.USD","LU2430703095.HKD"],"gpt_icon":0},{"id":"2519857938","title":"Johnson & Johnson’s Strategic Shift to Comprehensive Procedural Solutions Drives Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2519857938","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519857938?lang=en_us&edition=fundamental","pubTime":"2025-03-14 01:15","pubTimestamp":1741886113,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Josh Jennings has maintained their bullish stance on JNJ stock, giving a Buy rating on March 11. Josh Jennings has given his Buy r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/johnson-johnsons-strategic-shift-to-comprehensive-procedural-solutions-drives-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/johnson-johnsons-strategic-shift-to-comprehensive-procedural-solutions-drives-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JNJ"],"gpt_icon":0},{"id":"2519863822","title":"Pharma Stock Roundup: RHHBY Obesity Drug Rights Buyout, NVO Pipeline Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2519863822","media":"Zacks","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519863822?lang=en_us&edition=fundamental","pubTime":"2025-03-14 01:05","pubTimestamp":1741885500,"startTime":"0","endTime":"0","summary":"This week, Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche RHHBY announced a license and collaboration deal with Denmark’s Zealand Pharma to co-develop its lead obesity candidate petrelintide. Pfizer PFE and partner Arvinas ARVN announced mixed phase III data for breast cancer therapy, vepdegestrant. J&J JNJ and partner Protagonist Therapeutics’ investigational targeted oral peptide, icotrokinra met the primary endpoint of clinical response in ulcerative colitis study.Here's a recap of the week’s most important stories.NVO's Novel Obesity Treatment Disappoints in Phase III Study. Novo Nordisk’sphase III REDEFINE 2 study evaluating its next-gen subcutaneous obesity candidate, CagriSema, met its primary endpoint. CagriSema is a fixed-dose combination of a long-acting amylin analog, cagrilintide  and semaglutide .In the study, 61.9% of patients were given the highest dose of the drug.For the deal, Roche will make an upfro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharma-stock-roundup-rhhby-obesity-170500925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0225284248.USD","LU2430703095.HKD","IE00B4R5TH58.HKD","ITT","RHHBY","SG9999011175.SGD","LU0054578231.USD","LU0345769631.USD","SG9999003800.SGD","LU1032955483.USD","LU1894683264.USD","LU1244550221.USD","SG9999002232.USD","IE00BLSP4239.USD","PFE","ZLDPF","LU0466842654.USD","LU1093756168.USD","LU1066051811.HKD","LU0234570918.USD","BK4559","LU0795875086.SGD","LU1261432733.SGD","LU2602419157.SGD","MBC","LU1430594728.SGD","BK4599","LU0912757837.SGD","JNJ","IE00B42XCP33.USD","SG9999001176.USD","LU2089984988.USD","NVO","LU1732799900.SGD","03165","IE00BGHQF631.EUR","LU0345770993.USD","LU0058720904.USD","IE00BDGV0183.EUR","LU0053671581.USD","LU2112291526.USD","IE00B19Z3581.USD","LU2129689605.HKD","LU1718418525.SGD","BK4007","LU2505996509.AUD","LU1032466523.USD","LU0345769128.USD","ARVN","BK4581"],"gpt_icon":1},{"id":"2519887682","title":"Press Release: AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2519887682","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519887682?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:00","pubTimestamp":1741863600,"startTime":"0","endTime":"0","summary":"-- Landmark exclusive option and license deal with Takeda for ACI-24.060. with $100 million upfront and additional potential milestones of up to. about $2.1 billion plus royalties on sales upon commercialization. -- ACI-24.060 ABATE Phase 1b/2 trial showed encouraging interim safety and. tolerability data in Down syndrome  cohort; further interim results. in Alzheimer's disease  and DS expected in 2025. -- Enrollment progress in JNJ-2056  ReTain Phase 2b trial in. preclinical AD patients triggered second milestone payment of CHF 24.6. -- ACI-7104.056 VacSYn Phase 2 trial demonstrated positive interim safety. and immunogenicity results in Parkinson's disease ; further interim. \"The ability to innovate is key to our future success. Driven by our two drug discovery platforms, in 2024, we advanced multiple early-stage asse","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","LU0203345920.USD","LU1778281490.HKD","LU0234572021.USD","03160","IE00B2B36J28.USD","JNJ","ARIA","LU0792757196.USD","TM","LU1032466523.USD","BK4555","R","LU1221951129.SGD","LU1059921491.USD","LU0114720955.EUR","IE0009355771.USD","PET","LU1244550494.USD","BK4581","LU0640476718.USD","IE00BDGV0183.EUR","LU0234570918.USD","CBD","IE000M9KFDE8.USD","IE00B42XCP33.USD","BK4604","PSP","LU2430703095.HKD","IE00BSNM7G36.USD","IE00B4R5TH58.HKD","IE00BVYPNV92.GBP","BK4532","LU0912757837.SGD","ACIU","LU1169589451.USD","LU0098860793.USD","AAIC","LU1162221912.USD","SG9999002224.SGD","ACI","LU2089984988.USD","LU0345769128.USD","LU1244550577.SGD","LU0320765646.SGD","LU1506573853.SGD","AC","LU2505996509.AUD","PD","BK4007"],"gpt_icon":0},{"id":"2518751778","title":"Johnson & Johnson (NYSE:JNJ) Reports Positive Phase 2b Trial Results For Ulcerative Colitis Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2518751778","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518751778?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:36","pubTimestamp":1741714590,"startTime":"0","endTime":"0","summary":"Johnson & Johnson recently experienced a 12% price increase over the last quarter, largely driven by significant announcements regarding its clinical trials, particularly the ANTHEM-UC study, which showcased promising results in ulcerative colitis treatment. These positive results provided a boost to investor confidence amid overall market volatility, triggered by economic concerns and trade issues, including tariffs announced by the Trump administration. The broader market faced a decline of approximately 4% during the same period, with tensions contributing to uncertainty. Despite a slight dip in net income for the fourth quarter of 2024, JNJ's continued commitment to product innovation, evidenced by multiple successful trials such as ICONIC-LEAD for psoriasis, has maintained its appeal. Additionally, the company's consistent dividend payouts of $1.24 per share demonstrate resilience, offering investors a sense of stability against the backdrop of broader market fluctuations.This art","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnson-nyse-jnj-reports-173630504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1244550221.USD","LU2430703178.SGD","BK4504","IE00BJT1NW94.SGD","IE00BGHQF631.EUR","IE00B3PB1722.GBP","LU1023059063.AUD","SG9999002232.USD","BK4568","LU1061106388.HKD","JNJ","IE00B4R5TH58.HKD","LU0234572021.USD","IE00B42XCP33.USD","BK4581","LU0234570918.USD","LU0640476718.USD","LU2505996509.AUD","LU0889566641.SGD","LU1066051498.USD","BK4585","BK4559","LU1221951129.SGD","LU0203345920.USD","LU0122379950.USD","LU1718418525.SGD","LU2133065610.SGD","LU0345770308.USD","LU1074936037.SGD","LU0345770993.USD","LU2430703251.USD","SG9999002224.SGD","LU0345769128.USD","LU2468319806.SGD","LU2112291526.USD","IE00B2B36J28.USD","LU1032955483.USD","LU1935042991.SGD","IE00B19Z3581.USD","IE00B1BXHZ80.USD","LU2089984988.USD","LU0058720904.USD","LU0320765646.SGD","LU0795875169.SGD","LU1221951046.USD","BK4592","NYSE","IE0009355771.USD","LU0466842654.USD","LU0098860793.USD"],"gpt_icon":0},{"id":"2518727781","title":"PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2518727781","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518727781?lang=en_us&edition=fundamental","pubTime":"2025-03-12 00:15","pubTimestamp":1741709700,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics, Inc. PTGX announced positive top-line data from the phase IIb ANTHEM-UC study, which evaluated icotrokinra , an investigational targeted oral peptide that selectively blocks the IL-23 receptor, for treating adults with moderately to severely active ulcerative colitis , a chronic disease of the large intestine.The ANTHEM-UC study, conducted by Protagonist's partner, Johnson & Johnson JNJ, met its primary endpoint of clinical response in all icotrokinra dose groups.Treatment with icotrokinra also demonstrated clinically meaningful differences in key secondary endpoints of clinical remission, symptomatic remission and endoscopic improvement at week 12 versus placebo in the ANTHEM-UC study.Shares of PTGX were up 45.9% on March 10 following the announcement of the news.In the past year, shares of Protagonist have rallied 87.4% against the industry’s decline of 8.5%.The randomized, placebo-controlled phase IIb ANTHEM-UC study evaluated the safety and efficacy of thr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ptgx-j-j-partnered-drug-161500020.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1066051498.USD","PTGX","IE00B2B36J28.USD","LU2602419157.SGD","LU1914381329.SGD","LU1732800096.USD","LU1929549753.HKD","LU0098860793.USD","LU1989771016.USD","LU2360032135.SGD","LU1244550577.SGD","LU1585245621.USD","IE00B42XCP33.USD","IE00BVYPNV92.GBP","BK4592","IE00BGHQF631.EUR","LU0792757196.USD","IE0034235303.USD","BK4534","LU2125154778.USD","IE00BFXG1179.USD","BK4588","JNJ","LU2430703178.SGD","LU2125154935.USD","BK4007","BK4532","SG9999002232.USD","LU1221951046.USD","LU0345770993.USD","LU1244550221.USD","LU2129689431.USD","IE000M9KFDE8.USD","LU1291159041.SGD","LU2133065610.SGD","BK4581","BK4585","IE00B4R5TH58.HKD","LU0795875086.SGD","LU1023059063.AUD","LU0640476718.USD","LU1061106388.HKD","BMY","LU0203347892.USD","BMRN","LU1323610961.USD","LU1868836591.USD","LU2347655156.SGD","LU1674673428.USD","LU2468319806.SGD"],"gpt_icon":0},{"id":"2518445387","title":"Protagonist Therapeutics Soars as Icotrokinra Drives Breakthrough Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2518445387","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518445387?lang=en_us&edition=fundamental","pubTime":"2025-03-11 21:29","pubTimestamp":1741699755,"startTime":"0","endTime":"0","summary":"March 11, 2025 - The stock of Protagonist Therapeutics  dramatically increased by 45.82% on Monday after it declared successful results from the Phase 2b ANTHEM-UC study of icotrokinra .GuruFocus has detected 5 Warning Signs with PTGX.The joint development project of Protagonist Therapeutics and Johnson & Johnson  produced Icotrokinra as their first-in-class targeted oral peptide. Icotrokinra is a pill taken orally to treat plaque psoriasis , and ulcerative colitis.Icotrokinra works by blocking the IL-23 receptor selectively and the study achieved a 63.5% clinical response at its highest dose after twelve weeks and the result is only 27% to placebo. The treatment presented a good safety outcome and showed improvement until Week 28.PTGX stands as an interesting investment material since it successfully turned around in 2024.In the biotech industry, it is quite common that in the first years the companies often face financial losses for the high cost of initial research and developments ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/protagonist-therapeutics-soars-icotrokinra-drives-132915786.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1244550577.SGD","IE00BFTCPJ56.SGD","LU2129689431.USD","LU1718418525.SGD","LU1732800096.USD","LU2592432038.USD","LU1162221912.USD","IE00B4R5TH58.HKD","LU0234572021.USD","LU1244550221.USD","BK4139","LU2129689605.HKD","IE0034235303.USD","LU0098860793.USD","LU0203347892.USD","IE000M9KFDE8.USD","LU1585245621.USD","LU1066051811.HKD","LU1506573853.SGD","LU0795875086.SGD","LU1894683264.USD","LU2468319806.SGD","BK4592","BK4550","JNJ","LU2089984988.USD","IE0002141913.USD","IE00BDGV0183.EUR","LU0345770993.USD","LU1061106388.HKD","LU0889566641.SGD","LU0882574055.USD","LU2505996509.AUD","LU0792757196.USD","IE00B1BXHZ80.USD","LU2129689514.USD","LU2430703095.HKD","LU0122379950.USD","LU1929549753.HKD","IE00BSNM7G36.USD","BK4504","IE0009355771.USD","LU1221951129.SGD","PTGX","BK4588","BK4534","SG9999002232.USD","BK4533","LU1066051498.USD","LU0345769128.USD"],"gpt_icon":0},{"id":"2518749844","title":"TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2518749844","media":"ACCESS Newswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518749844?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:05","pubTimestamp":1741694700,"startTime":"0","endTime":"0","summary":"Dr. Tendler oversaw 30 Major Drug Approvals, including worldwide approvals for J&J's transformational treatments in hematologic malignancies, prostate, lung and bladder cancers. Dr. Tendler also oversaw 13 FDA Breakthrough Designations accelerating the early development of promising investigational medicines intended for treatment of serious oncology indications. TAMPA, FL / ACCESS Newswire / March 11, 2025 / TuHURA Biosciences, Inc.  , a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, today announced it has appointed Craig L. Tendler, M.D. to its Board of Directors effective March 10, 2025.Dr. Tendler added, \"TuHURA has established a science-based portfolio of novel complementary technologies and late-stage drug candidates that I believe has the potential to make a significant impact on the immuno-oncology treatment landscape. The data demonstrated to date are promising and underscore the ability of one o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tuhura-biosciences-inc-appoints-craig-120500961.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1023057109.AUD","TME","BK4552","BK4203","BK4565","GMRE","LU2039709279.SGD","BK4509","JNJ","BK4225","BK4548","BK4571","BK4563","IE00B12V2V27.USD","BK4108","BK4535","IE00BYQNZ168.SGD","LU0359201612.USD","01698","BK4531","SG9999011746.SGD","BK4526","HURA","BK4139","LU0359202008.SGD","IE00BYTNYN87.SGD"],"gpt_icon":0},{"id":"2518771704","title":"Breakfast News: The Rout Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=2518771704","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518771704?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:30","pubTimestamp":1741692600,"startTime":"0","endTime":"0","summary":"Nasdaq's big one-day fall, Tesla on the ropes, big stock moves, and more...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/breakfast-news/2025/03/11/breakfast-news-the-rout-continues/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["IE00B3PB1722.GBP","IE00BFTCPJ56.SGD","LU1066051498.USD","LU1674673691.USD","LU1162221912.USD","IE00B4R5TH58.HKD","LU1244550221.USD","IE00B42XCP33.USD","IE0034235303.USD","LU1914381329.SGD","BK4581","BK4568","LU1066051811.HKD","IE00BVYPNV92.GBP","LU0058720904.USD","BK4592","GDP","LU0320765646.SGD","BK4550","JNJ","LU0203345920.USD","LU1032466523.USD","LU2089984988.USD","LU2430703251.USD","IE00BGHQF631.EUR","IE00B7SZLL34.SGD","LU1244550494.USD","LU1061106388.HKD","SG9999002224.SGD","BK4585","LU1059921491.USD","LU0882574055.USD","LU0795875169.SGD","IPO","LU2112291526.USD","LU1261432733.SGD","LU0640476718.USD","LU1221951046.USD","LU2430703095.HKD","LU1929549753.HKD","BK4504","BK4559","LU0345769631.USD","SG9999001440.SGD","LU1430594728.SGD","LU0345770308.USD","LU0114720955.EUR","LU1267930813.SGD","LU0345769128.USD","LU2347655156.SGD"],"gpt_icon":0},{"id":"2518748469","title":"Genmab sinks as J&J opts not to develop Darzalex successor; stock upgraded","url":"https://stock-news.laohu8.com/highlight/detail?id=2518748469","media":"Investing.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518748469?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:06","pubTimestamp":1741691214,"startTime":"0","endTime":"0","summary":"Investing.com -- Genmab   announced on Monday, March 10, that Johnson&Johnson  has chosen not to proceed with the development of GEN3014 , a next-gen version of their megablockbuster cancer drug, Darzalex.Genmab’s U.S.-listed shares closed 9% lower Monday and fell by an additional 3.6% in Tuesday’s premarket trade.GEN3014, also known as HexaBody-CD38, is an investigational monoclonal antibody developed by Genmab that targets the CD38 protein on multiple myeloma cells, enhancing immune-mediated tumor cell destruction.The company held an investor call to discuss the decision, during which it shared initial data from a head-to-head study comparing GEN3014 to Darzalex.While the results suggested potentially deeper responses, they were not compelling enough for J&J or Genmab to pursue further development of GEN3014 for other indications.Following the post-announcement stock pullback, analysts at William Blair upgraded Genmab stock to an Outperform rating.“With a steady cadence of Phase III ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genmab-sinks-j-j-opts-110654356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["JNJ","GMAB"],"gpt_icon":0},{"id":"2518953787","title":"BUZZ-Genmab falls after J&J Hexabody opt-out","url":"https://stock-news.laohu8.com/highlight/detail?id=2518953787","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518953787?lang=en_us&edition=fundamental","pubTime":"2025-03-11 16:20","pubTimestamp":1741681247,"startTime":"0","endTime":"0","summary":"BUZZ-Genmab falls after J&J Hexabody opt-out** Shares in Genmab GMAB.CO fall 5.4% after Johnson & Johnson JNJ.N opted out of further clinical development of the Hexabody-CD38 cancer drug on Monday** Van Lanschot Kempen says that Hexabody did not differentiate enough from Darzalex, the company's flagship drug, and neither Genmab nor J&J will take the project forward** While Kempen says \"the shares are now free to perform\" without this overhang, Jyske Bank does not expect a quick rebound but rather a slow regain of market confidence** Kempen expects continued earnings momentum and growing appreciation for another cancer drug Epkinly as a major growth driver** Genmab says J&J opt-out does not impact its 2025 guidance  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nL8N3PU0BD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889566641.SGD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","IE00BVYPNV92.GBP","LU1023059063.AUD","LU1261432733.SGD","LU0466842654.USD","JNJ","LU2430703095.HKD","IE00B7SZLL34.SGD","LU1267930813.SGD","LU2505996681.GBP","LU0058720904.USD","LU0882574055.USD","BK4007","LU2133065610.SGD","LU1074936037.SGD","BK4559","SG9999002232.USD","IE00BJJMRZ35.SGD","LU1718418525.SGD","LU2129689605.HKD","IE00BGHQF631.EUR","IE0002141913.USD","LU0234570918.USD","LU1280957306.USD","LU1221951129.SGD","LU0792757196.USD","LU1244550494.USD","BK4534","BK4592","LU1244550221.USD","LU0122379950.USD","IE00BDGV0183.EUR","LU0640476718.USD","LU2505996509.AUD","BK4585","LU0203345920.USD","SG9999001440.SGD","LU0234572021.USD","LU1066051498.USD","LU2430703251.USD","IE0009355771.USD","IE00B3PB1722.GBP","LU0289739699.SGD","LU2129689514.USD","LU1059921491.USD","LU2592432038.USD","LU1935042991.SGD","BK4532"],"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":19,"totalSize":400,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JNJ\",params:#limit:5,,,undefined,":[{"date":"2025-05-27","symbol":"JNJ","amount":1.3,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-27","defaultRemindTime":1748352600000,"name":"强生","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-10","payableDate":"2025-05-27","currency":"USD","dateTimestamp":1748318400000,"payDate":"2025-06-10"},{"market":"US","date":"2025-04-15","symbol":"JNJ","fiscalQuarterEnding":"2025/03","expectedEps":2.57,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1744689600000,"reportTimeType":"pre","actualEps":2.77},{"date":"2025-02-18","symbol":"JNJ","amount":1.24,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-18","defaultRemindTime":1739889000000,"name":"强生","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-04","payableDate":"2025-02-18","currency":"USD","dateTimestamp":1739854800000,"payDate":"2025-03-04"},{"market":"US","date":"2025-01-22","symbol":"JNJ","fiscalQuarterEnding":"2024/12","expectedEps":2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1737522000000,"reportTimeType":"pre","actualEps":2.04},{"date":"2024-11-26","symbol":"JNJ","amount":1.24,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-26","defaultRemindTime":1732631400000,"name":"强生","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-10","payableDate":"2024-11-26","currency":"USD","dateTimestamp":1732597200000,"payDate":"2024-12-10"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JNJ\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-21","recordDate":"2015-05-26","paymentDate":"2015-06-09","value":0.75,"currency":"USD"},{"executeDate":"2015-08-21","recordDate":"2015-08-25","paymentDate":"2015-09-08","value":0.75,"currency":"USD"},{"executeDate":"2015-11-20","recordDate":"2015-11-24","paymentDate":"2015-12-08","value":0.75,"currency":"USD"},{"executeDate":"2016-02-19","recordDate":"2016-02-23","paymentDate":"2016-03-08","value":0.75,"currency":"USD"},{"executeDate":"2016-05-20","recordDate":"2016-05-24","paymentDate":"2016-06-07","value":0.8,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JNJ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1923,"buy":0.2692,"hold":0.5385,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2692,"analysts":26,"updateTime":1744171200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JNJ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JNJ","date":"2025-04-25","current":17.091836,"percent":0.187344,"low":8.579006,"twenty":21.086751,"median":23.911734,"eighty":27.898419,"high":36.412821,"avg":22.732897,"sd":6.732846,"marketCap":372772933115},"quantilePoints":[{"date":"2020-05-01","current":22.759176,"twenty":18.735775,"median":23.109347,"eighty":27.599044,"marketCap":390684023595},{"date":"2020-05-08","current":22.822102,"twenty":19.127953,"median":23.109347,"eighty":27.599044,"marketCap":391764207354},{"date":"2020-05-15","current":23.089153,"twenty":19.382974,"median":23.109347,"eighty":27.599044,"marketCap":396348401845},{"date":"2020-05-22","current":22.157545,"twenty":19.475347,"median":23.109347,"eighty":27.599044,"marketCap":380356413017},{"date":"2020-05-29","current":22.829776,"twenty":19.5115,"median":23.109347,"eighty":27.599044,"marketCap":391895937081},{"date":"2020-06-05","current":22.607234,"twenty":19.590503,"median":23.109347,"eighty":27.599044,"marketCap":388075775005},{"date":"2020-06-12","current":21.816825,"twenty":19.649079,"median":23.109347,"eighty":27.599044,"marketCap":374507613150},{"date":"2020-06-19","current":22.074667,"twenty":19.775373,"median":23.109347,"eighty":27.599044,"marketCap":378933731969},{"date":"2020-06-26","current":21.150732,"twenty":19.950076,"median":23.109347,"eighty":27.599044,"marketCap":363073472868},{"date":"2020-07-02","current":21.635721,"twenty":19.98339,"median":23.109347,"eighty":27.599044,"marketCap":371398791598},{"date":"2020-07-10","current":21.85059,"twenty":20.011787,"median":23.109347,"eighty":27.599044,"marketCap":375087223947},{"date":"2020-07-17","current":25.912196,"twenty":20.076078,"median":23.131106,"eighty":27.599044,"marketCap":393476693802},{"date":"2020-07-24","current":25.681516,"twenty":20.125159,"median":23.159117,"eighty":27.599044,"marketCap":389973813117},{"date":"2020-07-31","current":25.272331,"twenty":20.149539,"median":23.193752,"eighty":27.599044,"marketCap":383760349716},{"date":"2020-08-07","current":25.764739,"twenty":20.181909,"median":23.222825,"eighty":27.599044,"marketCap":391237568385},{"date":"2020-08-14","current":25.702321,"twenty":20.22081,"median":23.257402,"eighty":27.599044,"marketCap":390289751934},{"date":"2020-08-21","current":26.486013,"twenty":20.241265,"median":23.27709,"eighty":27.599044,"marketCap":402190114041},{"date":"2020-08-28","current":26.638591,"twenty":20.271241,"median":23.306845,"eighty":27.599044,"marketCap":404506998699},{"date":"2020-09-04","current":25.763006,"twenty":20.293663,"median":23.353075,"eighty":27.599044,"marketCap":391211240150},{"date":"2020-09-11","current":25.622565,"twenty":20.348379,"median":23.394637,"eighty":27.599044,"marketCap":389078653135},{"date":"2020-09-18","current":25.865302,"twenty":20.493086,"median":23.413631,"eighty":27.599044,"marketCap":392764606000},{"date":"2020-09-25","current":25.254993,"twenty":20.589134,"median":23.432295,"eighty":27.599044,"marketCap":383497067368},{"date":"2020-10-02","current":25.355555,"twenty":20.66024,"median":23.457245,"eighty":27.599044,"marketCap":385024104984},{"date":"2020-10-09","current":26.175658,"twenty":20.718013,"median":23.519753,"eighty":27.599044,"marketCap":397477360020},{"date":"2020-10-16","current":22.955443,"twenty":20.777568,"median":23.52089,"eighty":27.599044,"marketCap":389921156647},{"date":"2020-10-23","current":22.509743,"twenty":20.802059,"median":23.52089,"eighty":27.599044,"marketCap":382350497681},{"date":"2020-10-30","current":21.249731,"twenty":20.852405,"median":23.52089,"eighty":27.599044,"marketCap":360947925757},{"date":"2020-11-06","current":22.046344,"twenty":20.90683,"median":23.52089,"eighty":27.599044,"marketCap":374479195092},{"date":"2020-11-13","current":23.231964,"twenty":20.932588,"median":23.52089,"eighty":27.599044,"marketCap":394618146532},{"date":"2020-11-20","current":22.683324,"twenty":20.94836,"median":23.52089,"eighty":27.599044,"marketCap":385298945473},{"date":"2020-11-27","current":22.317564,"twenty":20.961808,"median":23.52089,"eighty":27.599044,"marketCap":379086144768},{"date":"2020-12-04","current":23.289308,"twenty":20.97761,"median":23.52089,"eighty":27.599044,"marketCap":395592187321},{"date":"2020-12-11","current":23.704663,"twenty":21.021529,"median":23.531213,"eighty":27.599044,"marketCap":402647401682},{"date":"2020-12-18","current":23.946436,"twenty":21.042546,"median":23.534826,"eighty":27.599044,"marketCap":406754168250},{"date":"2020-12-24","current":23.630271,"twenty":21.070826,"median":23.548153,"eighty":27.599044,"marketCap":401383781199},{"date":"2020-12-31","current":24.391238,"twenty":21.097347,"median":23.558663,"eighty":27.599044,"marketCap":414309565719},{"date":"2021-01-08","current":24.803493,"twenty":21.111621,"median":23.586469,"eighty":27.599044,"marketCap":421312129226},{"date":"2021-01-15","current":24.843788,"twenty":21.147258,"median":23.595957,"eighty":27.599044,"marketCap":421996590321},{"date":"2021-01-22","current":25.347483,"twenty":21.183404,"median":23.599747,"eighty":27.599044,"marketCap":430552354005},{"date":"2021-01-29","current":29.186264,"twenty":21.19897,"median":23.614272,"eighty":30.081908,"marketCap":429446686083},{"date":"2021-02-05","current":29.422431,"twenty":21.226117,"median":23.637028,"eighty":30.081908,"marketCap":432921642410},{"date":"2021-02-12","current":29.803518,"twenty":21.248794,"median":23.655744,"eighty":30.081908,"marketCap":438528958301},{"date":"2021-02-19","current":29.159427,"twenty":21.257145,"median":23.669632,"eighty":30.081908,"marketCap":429051804682},{"date":"2021-02-26","current":28.309134,"twenty":21.271585,"median":23.6918,"eighty":30.081908,"marketCap":416540604911},{"date":"2021-03-05","current":27.887517,"twenty":21.285637,"median":23.70506,"eighty":30.12771,"marketCap":410336920526},{"date":"2021-03-12","current":28.556475,"twenty":21.311821,"median":23.72791,"eighty":30.12771,"marketCap":420179968572},{"date":"2021-03-19","current":28.635202,"twenty":21.329473,"median":23.741859,"eighty":30.12771,"marketCap":421338359462},{"date":"2021-03-26","current":29.510146,"twenty":21.34329,"median":23.767845,"eighty":30.081908,"marketCap":434212294590},{"date":"2021-04-01","current":29.134403,"twenty":21.35594,"median":23.773685,"eighty":30.081908,"marketCap":428683610793},{"date":"2021-04-09","current":28.851701,"twenty":21.4211,"median":23.786177,"eighty":30.12771,"marketCap":424523934412},{"date":"2021-04-16","current":29.028837,"twenty":21.428126,"median":23.790128,"eighty":30.12771,"marketCap":427130313916},{"date":"2021-04-23","current":28.830009,"twenty":21.447349,"median":23.796452,"eighty":30.12771,"marketCap":435765591466},{"date":"2021-04-30","current":28.351474,"twenty":21.475831,"median":23.817885,"eighty":30.12771,"marketCap":428532531568},{"date":"2021-05-07","current":29.356747,"twenty":21.503927,"median":23.841105,"eighty":30.12771,"marketCap":443727226505},{"date":"2021-05-14","current":29.656412,"twenty":21.531317,"median":23.877391,"eighty":30.12771,"marketCap":448256667630},{"date":"2021-05-21","current":29.785338,"twenty":21.561813,"median":23.895323,"eighty":30.12771,"marketCap":450205380672},{"date":"2021-05-28","current":29.487415,"twenty":21.592765,"median":23.937312,"eighty":30.12771,"marketCap":445702273507},{"date":"2021-06-04","current":28.91596,"twenty":21.615414,"median":23.966133,"eighty":30.12771,"marketCap":437064734617},{"date":"2021-06-11","current":28.739994,"twenty":21.638518,"median":24.015189,"eighty":30.12771,"marketCap":434405004654},{"date":"2021-06-18","current":28.220806,"twenty":21.670392,"median":24.039278,"eighty":30.12771,"marketCap":426557484565},{"date":"2021-06-25","current":28.609326,"twenty":21.861141,"median":24.084813,"eighty":30.12771,"marketCap":432429957652},{"date":"2021-07-02","current":29.440374,"twenty":21.936844,"median":24.121091,"eighty":30.12771,"marketCap":444991256586},{"date":"2021-07-09","current":29.574527,"twenty":21.9912,"median":24.15923,"eighty":30.12771,"marketCap":447018971509},{"date":"2021-07-16","current":29.287057,"twenty":22.008978,"median":24.192461,"eighty":30.12771,"marketCap":442673868104},{"date":"2021-07-23","current":25.462436,"twenty":22.072979,"median":24.243827,"eighty":30.12771,"marketCap":452391099355},{"date":"2021-07-30","current":25.514348,"twenty":22.099856,"median":24.305908,"eighty":30.12771,"marketCap":453313416242},{"date":"2021-08-06","current":25.64918,"twenty":22.156186,"median":24.365597,"eighty":30.12771,"marketCap":455708974946},{"date":"2021-08-13","current":26.114424,"twenty":22.208673,"median":24.40122,"eighty":30.12771,"marketCap":463974968715},{"date":"2021-08-20","current":26.587076,"twenty":22.280598,"median":24.437878,"eighty":30.12771,"marketCap":472372586588},{"date":"2021-08-27","current":25.62251,"twenty":22.31426,"median":24.507475,"eighty":30.12771,"marketCap":455235128169},{"date":"2021-09-03","current":25.935142,"twenty":22.403746,"median":24.626763,"eighty":30.12771,"marketCap":460789665383},{"date":"2021-09-10","current":24.739435,"twenty":22.438026,"median":24.721919,"eighty":30.12771,"marketCap":439545534901},{"date":"2021-09-17","current":24.410504,"twenty":22.494978,"median":24.721919,"eighty":30.12771,"marketCap":433701424657},{"date":"2021-09-24","current":24.352719,"twenty":22.531175,"median":24.721919,"eighty":30.12771,"marketCap":432674756641},{"date":"2021-10-01","current":23.776349,"twenty":22.581732,"median":24.721919,"eighty":30.12771,"marketCap":422434401303},{"date":"2021-10-08","current":23.844506,"twenty":22.600481,"median":24.721919,"eighty":30.12771,"marketCap":423645343065},{"date":"2021-10-15","current":23.899328,"twenty":22.647017,"median":24.721919,"eighty":30.12771,"marketCap":424619361439},{"date":"2021-10-22","current":24.104584,"twenty":22.670383,"median":24.721919,"eighty":30.12771,"marketCap":430989968102},{"date":"2021-10-29","current":23.981957,"twenty":22.690905,"median":24.721919,"eighty":30.12771,"marketCap":428797394310},{"date":"2021-11-05","current":24.062938,"twenty":22.73421,"median":24.721919,"eighty":30.12771,"marketCap":430245322643},{"date":"2021-11-12","current":24.295572,"twenty":22.75379,"median":24.721919,"eighty":30.12771,"marketCap":434404825854},{"date":"2021-11-19","current":23.98343,"twenty":22.790525,"median":24.721919,"eighty":30.12771,"marketCap":428823720280},{"date":"2021-11-26","current":23.440125,"twenty":22.801141,"median":24.721919,"eighty":30.12771,"marketCap":419109437464},{"date":"2021-12-03","current":23.466628,"twenty":22.824465,"median":24.721919,"eighty":30.12771,"marketCap":419583304919},{"date":"2021-12-10","current":24.366246,"twenty":22.839493,"median":24.721919,"eighty":30.12771,"marketCap":435668472399},{"date":"2021-12-17","current":24.769675,"twenty":22.851504,"median":24.762774,"eighty":30.12771,"marketCap":442881788094},{"date":"2021-12-23","current":24.77262,"twenty":22.874439,"median":24.76352,"eighty":30.12771,"marketCap":442934440034},{"date":"2021-12-31","current":25.187828,"twenty":22.900154,"median":24.774698,"eighty":30.12771,"marketCap":450358363486},{"date":"2022-01-07","current":25.61187,"twenty":22.921295,"median":24.829881,"eighty":30.081908,"marketCap":457940242757},{"date":"2022-01-14","current":24.712253,"twenty":22.958017,"median":24.899153,"eighty":30.081908,"marketCap":441855075276},{"date":"2022-01-21","current":24.274959,"twenty":22.965167,"median":24.899153,"eighty":30.081908,"marketCap":434036262279},{"date":"2022-01-28","current":21.661741,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":452253833304},{"date":"2022-02-04","current":21.641566,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":451832617789},{"date":"2022-02-11","current":21.147276,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":441512837670},{"date":"2022-02-18","current":20.57272,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":429517246290},{"date":"2022-02-25","current":20.905188,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":436458514228},{"date":"2022-03-04","current":21.343441,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":445608367417},{"date":"2022-03-11","current":21.32707,"twenty":22.962882,"median":24.899153,"eighty":30.081908,"marketCap":445266562557},{"date":"2022-03-18","current":22.021361,"twenty":22.953432,"median":24.899153,"eighty":30.081908,"marketCap":459761966327},{"date":"2022-03-25","current":22.28334,"twenty":22.906658,"median":24.899153,"eighty":30.081908,"marketCap":465231566475},{"date":"2022-04-01","current":22.443298,"twenty":22.88299,"median":24.899153,"eighty":30.081908,"marketCap":468571178104},{"date":"2022-04-08","current":22.938288,"twenty":22.87009,"median":24.899153,"eighty":30.081908,"marketCap":478905566846},{"date":"2022-04-14","current":22.658675,"twenty":22.850073,"median":24.899153,"eighty":30.081908,"marketCap":473067820534},{"date":"2022-04-22","current":24.073645,"twenty":22.862939,"median":24.899153,"eighty":30.081908,"marketCap":477380389882},{"date":"2022-04-29","current":23.946685,"twenty":22.897881,"median":24.899153,"eighty":30.081908,"marketCap":474862769549},{"date":"2022-05-06","current":23.40395,"twenty":22.935305,"median":24.899153,"eighty":30.081908,"marketCap":464100336171},{"date":"2022-05-13","current":23.467645,"twenty":22.958017,"median":24.899153,"eighty":30.081908,"marketCap":465363409037},{"date":"2022-05-20","current":23.484896,"twenty":22.975012,"median":24.899153,"eighty":30.081908,"marketCap":465705491271},{"date":"2022-05-27","current":24.030285,"twenty":22.985845,"median":24.899153,"eighty":30.081908,"marketCap":476520552686},{"date":"2022-06-03","current":23.410585,"twenty":23.004816,"median":24.899153,"eighty":30.081908,"marketCap":464231906261},{"date":"2022-06-10","current":22.897044,"twenty":23.050406,"median":24.899153,"eighty":30.081908,"marketCap":454048381280},{"date":"2022-06-17","current":22.487007,"twenty":23.028812,"median":24.899153,"eighty":30.081908,"marketCap":445917349705},{"date":"2022-06-24","current":24.189523,"twenty":23.015811,"median":24.900273,"eighty":30.12771,"marketCap":479678234851},{"date":"2022-07-01","current":23.821949,"twenty":23.040512,"median":24.900273,"eighty":30.12771,"marketCap":472389251854},{"date":"2022-07-08","current":23.657404,"twenty":23.071416,"median":24.900273,"eighty":30.12771,"marketCap":469126313617},{"date":"2022-07-15","current":23.650769,"twenty":23.097851,"median":24.900273,"eighty":30.12771,"marketCap":468994743526},{"date":"2022-07-22","current":24.660616,"twenty":23.102569,"median":24.900273,"eighty":30.12771,"marketCap":452916878504},{"date":"2022-07-29","current":24.983365,"twenty":23.140839,"median":24.928435,"eighty":30.12771,"marketCap":458844475275},{"date":"2022-08-05","current":24.495207,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":449878971833},{"date":"2022-08-12","current":23.663478,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":434603436643},{"date":"2022-08-19","current":24.237528,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":445146448022},{"date":"2022-08-26","current":23.516029,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":431895381351},{"date":"2022-09-02","current":23.297002,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":427872736112},{"date":"2022-09-09","current":23.722171,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":435681400400},{"date":"2022-09-16","current":23.992734,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":440650550402},{"date":"2022-09-23","current":23.866758,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":438336872094},{"date":"2022-09-30","current":23.385758,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":429502827647},{"date":"2022-10-07","current":22.933389,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":421194619179},{"date":"2022-10-14","current":23.543228,"twenty":23.140839,"median":24.938619,"eighty":30.12771,"marketCap":432394925531},{"date":"2022-10-21","current":23.154405,"twenty":23.113317,"median":24.898033,"eighty":30.12771,"marketCap":443568940085},{"date":"2022-10-28","current":23.865676,"twenty":23.113317,"median":24.843788,"eighty":30.12771,"marketCap":457194748356},{"date":"2022-11-04","current":23.40302,"twenty":23.113317,"median":24.803493,"eighty":30.12771,"marketCap":448331648928},{"date":"2022-11-11","current":23.098677,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":442501350484},{"date":"2022-11-18","current":24.04719,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":460672011553},{"date":"2022-11-25","current":24.189125,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":463391074504},{"date":"2022-12-02","current":24.412947,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":467678827620},{"date":"2022-12-09","current":23.98441,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":459469349094},{"date":"2022-12-16","current":23.974857,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":459286335241},{"date":"2022-12-23","current":24.22188,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":464018550570},{"date":"2022-12-30","current":24.108604,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":461848529176},{"date":"2023-01-06","current":24.59992,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":471260670161},{"date":"2023-01-13","current":23.669149,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":453429891962},{"date":"2023-01-20","current":23.029074,"twenty":23.100329,"median":24.77262,"eighty":30.12771,"marketCap":441167963845},{"date":"2023-01-27","current":24.515611,"twenty":23.09784,"median":24.762774,"eighty":29.79261,"marketCap":439834577205},{"date":"2023-02-03","current":23.98808,"twenty":23.09784,"median":24.725504,"eighty":29.701392,"marketCap":430370146548},{"date":"2023-02-10","current":23.629592,"twenty":23.09784,"median":24.702141,"eighty":29.654503,"marketCap":423938516875},{"date":"2023-02-17","current":23.281951,"twenty":23.096013,"median":24.660616,"eighty":29.589162,"marketCap":417701480138},{"date":"2023-02-24","current":22.640351,"twenty":23.085296,"median":24.603297,"eighty":29.518959,"marketCap":406190534678},{"date":"2023-03-03","current":22.357292,"twenty":23.028549,"median":24.566079,"eighty":29.469644,"marketCap":401112176388},{"date":"2023-03-10","current":22.00746,"twenty":22.983363,"median":24.533047,"eighty":29.415426,"marketCap":394835846397},{"date":"2023-03-17","current":22.198308,"twenty":22.961748,"median":24.507475,"eighty":29.316327,"marketCap":398259841984},{"date":"2023-03-24","current":22.237641,"twenty":22.954123,"median":24.458598,"eighty":29.237465,"marketCap":398965513052},{"date":"2023-03-31","current":22.579982,"twenty":22.928011,"median":24.42796,"eighty":29.164815,"marketCap":405107464940},{"date":"2023-04-06","current":24.125619,"twenty":22.901879,"median":24.415005,"eighty":29.109707,"marketCap":432837724314},{"date":"2023-04-14","current":24.198457,"twenty":22.90067,"median":24.40122,"eighty":29.036089,"marketCap":434144522588},{"date":"2023-04-21","current":33.60045,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":427532123321},{"date":"2023-04-28","current":33.481314,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":426016237324},{"date":"2023-05-05","current":33.113231,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":421332755579},{"date":"2023-05-12","current":35.39488,"twenty":22.899462,"median":24.396569,"eighty":29.008716,"marketCap":450364456873},{"date":"2023-05-16","current":35.078285,"twenty":22.899462,"median":24.396569,"eighty":29.008716,"marketCap":446336102206},{"date":"2023-05-25","current":34.442897,"twenty":22.896558,"median":24.388256,"eighty":28.974086,"marketCap":438251418186},{"date":"2023-06-02","current":33.976799,"twenty":22.896316,"median":24.385274,"eighty":28.964288,"marketCap":432320784926},{"date":"2023-06-09","current":35.234384,"twenty":22.896073,"median":24.383122,"eighty":28.950456,"marketCap":448322304854},{"date":"2023-06-15","current":35.520199,"twenty":22.89583,"median":24.380969,"eighty":28.928156,"marketCap":451959013929},{"date":"2023-06-23","current":36.412821,"twenty":22.894676,"median":24.377907,"eighty":28.919594,"marketCap":463316736116},{"date":"2023-06-30","current":36.078638,"twenty":22.893522,"median":24.372178,"eighty":28.915612,"marketCap":459064583967},{"date":"2023-07-06","current":33.252114,"twenty":22.892945,"median":24.371306,"eighty":28.914218,"marketCap":423099894750},{"date":"2023-07-14","current":32.435159,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":412704958450},{"date":"2023-07-21","current":34.389724,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":437574843548},{"date":"2023-07-28","current":34.577457,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":451374121486},{"date":"2023-08-04","current":33.973355,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":443488171520},{"date":"2023-08-11","current":34.277968,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":447464594998},{"date":"2023-08-18","current":34.644301,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":452246699051},{"date":"2023-08-25","current":32.868384,"twenty":22.886611,"median":24.365921,"eighty":28.849875,"marketCap":429063890273},{"date":"2023-09-01","current":29.823849,"twenty":22.886611,"median":24.365921,"eighty":28.849875,"marketCap":389320523957},{"date":"2023-09-07","current":29.146873,"twenty":22.885028,"median":24.365597,"eighty":28.849755,"marketCap":380483275547},{"date":"2023-09-15","current":30.203841,"twenty":22.879503,"median":24.364936,"eighty":28.833726,"marketCap":394280941321},{"date":"2023-09-20","current":29.919769,"twenty":22.87674,"median":24.363504,"eighty":28.822576,"marketCap":390572668146},{"date":"2023-09-27","current":29.333179,"twenty":22.87009,"median":24.356583,"eighty":28.783898,"marketCap":382915324837},{"date":"2023-10-06","current":28.986391,"twenty":22.866716,"median":24.354651,"eighty":28.718771,"marketCap":378388342001},{"date":"2023-10-13","current":28.836976,"twenty":22.866716,"median":24.354651,"eighty":28.718771,"marketCap":376437886630},{"date":"2023-10-20","current":10.593286,"twenty":22.841783,"median":24.323515,"eighty":28.702887,"marketCap":366781928558},{"date":"2023-10-27","current":10.362392,"twenty":22.819032,"median":24.302934,"eighty":28.672744,"marketCap":358787469506},{"date":"2023-11-03","current":10.445631,"twenty":22.769044,"median":24.290222,"eighty":28.617079,"marketCap":361669539868},{"date":"2023-11-10","current":10.249567,"twenty":22.737382,"median":24.269161,"eighty":28.577268,"marketCap":354881014160},{"date":"2023-11-17","current":10.435898,"twenty":22.670731,"median":24.240678,"eighty":28.494304,"marketCap":361332520862},{"date":"2023-11-24","current":10.602761,"twenty":22.660327,"median":24.231704,"eighty":28.462978,"marketCap":367109989550},{"date":"2023-11-30","current":10.575646,"twenty":22.651742,"median":24.221347,"eighty":28.351474,"marketCap":366171150888},{"date":"2023-12-08","current":10.804387,"twenty":22.618791,"median":24.198457,"eighty":28.181371,"marketCap":374091097548},{"date":"2023-12-15","current":10.906591,"twenty":22.590739,"median":24.188733,"eighty":27.750808,"marketCap":377629797119},{"date":"2023-12-22","current":10.765452,"twenty":22.58102,"median":24.177986,"eighty":27.241581,"marketCap":372743021520},{"date":"2023-12-29","current":10.886428,"twenty":22.573561,"median":24.160465,"eighty":27.136313,"marketCap":376931686319},{"date":"2024-01-05","current":11.16801,"twenty":22.53203,"median":24.157661,"eighty":27.08647,"marketCap":386681164730},{"date":"2024-01-12","current":11.204163,"twenty":22.487074,"median":24.126144,"eighty":26.963348,"marketCap":387932949613},{"date":"2024-01-19","current":11.208335,"twenty":22.443298,"median":24.121091,"eighty":26.726065,"marketCap":388077386330},{"date":"2024-01-26","current":11.093616,"twenty":22.419215,"median":24.117255,"eighty":26.720851,"marketCap":384105376607},{"date":"2024-02-02","current":10.844498,"twenty":22.388887,"median":24.117255,"eighty":26.720851,"marketCap":381216642263},{"date":"2024-02-09","current":10.710277,"twenty":22.359324,"median":24.117255,"eighty":26.720851,"marketCap":376498376168},{"date":"2024-02-16","current":10.814367,"twenty":22.324374,"median":24.117255,"eighty":26.720851,"marketCap":380157439670},{"date":"2024-02-23","current":10.994416,"twenty":22.309859,"median":24.117255,"eighty":26.720851,"marketCap":386486701732},{"date":"2024-03-01","current":11.058142,"twenty":22.274272,"median":24.113418,"eighty":26.715636,"marketCap":388726855254},{"date":"2024-03-08","current":10.886151,"twenty":22.230938,"median":24.108604,"eighty":26.715636,"marketCap":382680849512},{"date":"2024-03-15","current":10.914049,"twenty":22.186179,"median":24.098462,"eighty":26.715636,"marketCap":383661560027},{"date":"2024-03-22","current":10.676861,"twenty":22.155506,"median":24.095837,"eighty":26.715636,"marketCap":375323710660},{"date":"2024-03-28","current":10.82836,"twenty":22.121795,"median":24.073645,"eighty":26.715636,"marketCap":380649331209},{"date":"2024-04-05","current":10.45407,"twenty":22.051165,"median":24.060772,"eighty":26.720851,"marketCap":367491915735},{"date":"2024-04-12","current":10.199745,"twenty":22.008009,"median":24.060772,"eighty":26.720851,"marketCap":358551620604},{"date":"2024-04-19","current":8.65562,"twenty":21.962919,"median":24.049911,"eighty":26.720851,"marketCap":351201782289},{"date":"2024-04-26","current":8.719762,"twenty":21.891108,"median":24.032177,"eighty":26.715636,"marketCap":353804347988},{"date":"2024-05-03","current":9.377517,"twenty":21.784557,"median":24.00846,"eighty":26.715636,"marketCap":360809343115},{"date":"2024-05-10","current":9.373138,"twenty":21.660958,"median":23.990791,"eighty":26.715636,"marketCap":360640875572},{"date":"2024-05-17","current":9.650236,"twenty":21.622619,"median":23.98343,"eighty":26.715636,"marketCap":371302464353},{"date":"2024-05-24","current":9.363756,"twenty":21.575231,"median":23.974857,"eighty":26.715636,"marketCap":360279873695},{"date":"2024-05-31","current":9.087284,"twenty":21.542202,"median":23.962574,"eighty":26.715636,"marketCap":349642351706},{"date":"2024-06-07","current":9.158591,"twenty":21.483343,"median":23.946685,"eighty":26.715636,"marketCap":352385965974},{"date":"2024-06-14","current":9.097918,"twenty":21.446612,"median":23.929686,"eighty":26.720851,"marketCap":350051487167},{"date":"2024-06-21","current":9.24366,"twenty":21.36611,"median":23.912184,"eighty":26.726065,"marketCap":355659049663},{"date":"2024-06-28","current":9.11981,"twenty":21.343437,"median":23.902291,"eighty":26.770681,"marketCap":350893824881},{"date":"2024-07-05","current":9.11293,"twenty":21.329201,"median":23.877595,"eighty":26.770681,"marketCap":350629090171},{"date":"2024-07-12","current":9.363756,"twenty":21.294957,"median":23.864994,"eighty":26.770681,"marketCap":360279873695},{"date":"2024-07-15","current":9.375015,"twenty":21.282675,"median":23.856229,"eighty":26.770681,"marketCap":360713075948},{"date":"2024-08-02","current":10.179086,"twenty":21.325495,"median":23.875766,"eighty":26.859196,"marketCap":386988491906},{"date":"2024-08-09","current":10.144894,"twenty":21.325495,"median":23.875766,"eighty":26.859196,"marketCap":385688580326},{"date":"2024-08-16","current":10.073344,"twenty":21.285584,"median":23.875766,"eighty":26.859196,"marketCap":382968394983},{"date":"2024-08-23","current":10.279762,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":390816009337},{"date":"2024-08-30","current":10.398801,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":395341627431},{"date":"2024-09-06","current":10.446923,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":397171132618},{"date":"2024-09-13","current":10.424762,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":396328597334},{"date":"2024-09-20","current":10.436159,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":396761901194},{"date":"2024-09-27","current":10.218977,"twenty":21.249331,"median":23.875766,"eighty":26.859196,"marketCap":388505055417},{"date":"2024-10-04","current":10.162623,"twenty":21.244537,"median":23.875766,"eighty":26.859196,"marketCap":386362608553},{"date":"2024-10-11","current":10.163256,"twenty":21.204151,"median":23.875766,"eighty":26.859196,"marketCap":386386680990},{"date":"2024-10-18","current":26.962637,"twenty":21.150041,"median":23.875766,"eighty":26.960825,"marketCap":395919365911},{"date":"2024-10-25","current":26.835716,"twenty":21.150041,"median":23.889093,"eighty":26.967068,"marketCap":394055651827},{"date":"2024-10-31","current":26.333991,"twenty":21.150041,"median":23.889093,"eighty":26.967068,"marketCap":386688325532},{"date":"2024-11-08","current":25.697817,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":377346748401},{"date":"2024-11-15","current":24.90096,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":365645700757},{"date":"2024-11-22","current":25.496144,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":374385372146},{"date":"2024-11-29","current":25.415802,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":373205636889},{"date":"2024-12-06","current":24.515649,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":359987786773},{"date":"2024-12-13","current":23.977852,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":352090783425},{"date":"2024-12-20","current":23.541712,"twenty":21.14935,"median":23.870477,"eighty":26.963219,"marketCap":345686506319},{"date":"2024-12-27","current":23.869637,"twenty":21.14935,"median":23.866899,"eighty":26.862222,"marketCap":350501752263},{"date":"2025-01-03","current":23.613856,"twenty":21.14935,"median":23.846327,"eighty":26.797423,"marketCap":346745860427},{"date":"2025-01-10","current":23.326922,"twenty":21.148658,"median":23.835219,"eighty":26.622639,"marketCap":342532520226},{"date":"2025-01-17","current":24.228715,"twenty":21.148658,"median":23.815222,"eighty":26.492194,"marketCap":355774446572},{"date":"2025-01-24","current":25.099803,"twenty":21.148658,"median":23.815222,"eighty":26.458097,"marketCap":353053832614},{"date":"2025-01-31","current":26.166168,"twenty":21.148658,"median":23.815222,"eighty":26.458097,"marketCap":368053323729},{"date":"2025-02-07","current":26.275715,"twenty":21.148658,"median":23.815222,"eighty":26.451023,"marketCap":369594202431},{"date":"2025-02-14","current":26.915876,"twenty":21.148658,"median":23.815222,"eighty":26.482684,"marketCap":378598712347},{"date":"2025-02-21","current":27.331738,"twenty":21.148658,"median":23.815222,"eighty":26.556741,"marketCap":384448233538},{"date":"2025-02-28","current":28.02496,"twenty":21.148658,"median":23.815222,"eighty":26.658356,"marketCap":394199081144},{"date":"2025-03-07","current":28.384408,"twenty":21.147967,"median":23.81824,"eighty":26.827657,"marketCap":399255076200},{"date":"2025-03-14","current":27.898297,"twenty":21.147967,"median":23.837873,"eighty":27.012809,"marketCap":392417444792},{"date":"2025-03-21","current":27.929289,"twenty":21.164087,"median":23.864994,"eighty":27.693395,"marketCap":392853376781},{"date":"2025-03-28","current":27.948135,"twenty":21.248131,"median":23.876669,"eighty":27.88488,"marketCap":393118460031},{"date":"2025-04-04","current":27.381051,"twenty":21.248131,"median":23.905254,"eighty":27.898419,"marketCap":385141864048},{"date":"2025-04-11","current":25.474211,"twenty":21.248531,"median":23.905255,"eighty":27.898389,"marketCap":358320258825},{"date":"2025-04-17","current":17.005945,"twenty":21.223208,"median":23.911283,"eighty":27.898389,"marketCap":370899663970},{"date":"2025-04-25","current":17.091836,"twenty":21.086751,"median":23.911734,"eighty":27.898419,"marketCap":372772933115}],"updateTime":1745740288153}}}